Carl June

Type: Person
Name: Carl June
First reported 19 hours ago - Updated 3 hours ago - 1 reports

Philadelphia Ronald McDonald House launches campaign to add rooms

When the Philadelphia Ronald McDonald House opened 40 years ago last week, it only had seven rooms.Since then, the first Ronald McDonald House in the country has grown into two houses, one on 39th and Chestnut streets with 45 rooms and one on Front and ... [Published The Daily Pennsylvanian - 19 hours ago]
First reported 9 hours ago - Updated 9 hours ago - 1 reports

Harnessing the Power of Modified T Cells to Treat Cancer

New data from the University of Pennsylvania and The Children’s Hospital of Philadelphia reveal that an immunotherapy, named CTL019, helped 90% of children and adults with acute lymphoblastic leukemia (ALL) who had failed to respond to prior treatments ... [Published PharmTech.com - 9 hours ago]
First reported Oct 19 2014 - Updated Oct 19 2014 - 1 reports

Nominations open for $100,000 Taubman Prize

Contact InformationAvailable for logged-in reporters onlyNewswise — Ann Arbor, Mich. – Physician-scientists worldwide are invited to apply for the 2015 Taubman Prize for Excellence in Translational Medical Science, the A. Alfred Taubman Medical Research ... [Published Newswise - Oct 19 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 1 reports

Personalized cellular therapy achieves complete remission in 90 percent of acute lymphoblastic leukemia patients studied

Ninety percent of children and adults with acute lymphoblastic leukemia (ALL) who had relapsed multiple times or failed to respond to standard therapies went into remission after receiving an investigational personalized cellular therapy, CTL019, developed ... [Published Medical Xpress - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 16 2014 - 1 reports

Lab-Made Blood Cells Hunt Cancer, Leading to Remissions

The blood cells of cancer patients, reprogrammed by doctors to attack their leukemia and re-infused back into the patients’ veins, led to complete remissions in 27 of 30 people. That’s especially exciting because those patients had failed all conventional ... [Published The Verge - Oct 15 2014]
First reported Oct 15 2014 - Updated Oct 15 2014 - 1 reports

Immunotherapy Study Funded by The Leukemia & Lymphoma Society Demonstrates Remarkable Results in Patients with Acute Lymphoblastic Leukemia

WHITE PLAINS, N.Y. , Oct. 15, 2014 /PRNewswire-USNewswire/ -- Funding from The Leukemia & Lymphoma Society (LLS) over the past 22 years helped advance a study published today in the New England Journal of Medicine showing that 90 percent of children and ... [Published Indianapolis Business Journal - Oct 15 2014]
First reported Oct 12 2014 - Updated Oct 12 2014 - 1 reports

Taubman Institute awards annual $100,000 research grant

Friday morning, the A. Alfred Taubman Medical Research Institute presented its $100,000 Taubman Prize for Excellence in Translation Medical Science to Carl June, the Richard W. Vague Professor in Immunotherapy, Pathology and Laboratory Medicine at the ... [Published Michigan Daily - Oct 12 2014]
First reported Sep 25 2014 - Updated Sep 26 2014 - 1 reports

Adaptimmune gathers $104M to fuel hot immuno-oncology tech race

Back at the beginning of June, Adaptimmune only had about a million pounds sterling in the bank. Then GlaxoSmithKline ($GSK) completed a $350 million collaboration deal on its immuno-oncology tech and a lead therapy. And now a slate of top-tier biotech ... [Published FierceBiotech - Sep 25 2014]
First reported Sep 24 2014 - Updated Sep 24 2014 - 1 reports

Dale Edward Nau

, at Mercy New Life Hospice in Lorain, surrounded by his loving family.He was preceded in death by his beloved wife of 37 years, Patricia (nee Fenelon) Nau; parents, William, Jr. and Matilda (nee Emerick) Nau; sisters, Dorothy Enz and Beverly Stempowski; ... [Published Elyria Chronicle Telegram - Sep 24 2014]
First reported Sep 16 2014 - Updated Sep 16 2014 - 1 reports

Novartis, University Of Pennsylvania To Build Center For CAR Research

By Estel Grace MasangkayNovartis and the University of Pennsylvania announced their plans to build the Center for Advanced Cellular Therapeutics (CACT) on the Penn Medicine campus in Philadelphia.The center will be dedicated to advancing research in Chimeric ... [Published Bioresearch Online - Sep 16 2014]
First reported Sep 11 2014 - Updated Sep 12 2014 - 1 reports

Novartis commits $20M to back a new CAR-T research center at Penn

With a lead chimeric antigen receptor program holding on to a breakthrough drug designation at the FDA and Penn's Carl June grabbing headlines for the data his team is seeing among cancer victims, their big pharma backer Novartis ($NVS) is contributing ... [Published FierceBiotech - Sep 11 2014]
First reported Aug 05 2014 - Updated Aug 05 2014 - 1 reports

The Alliance for Regenerative Medicine Holds Fourth Annual Partnering Forum at the Meeting on the Mesa - October 7 and 8

Meeting Will Include Plenary Sessions on Latest Developments in Both Gene and Cell Therapy; UPenn's Carl June, M.D. Featured Speaker at Program's Public Forum ... [Published Marketwire - Breaking News Releases - Aug 05 2014]

Quotes

...all cell and gene therapies in that it’s actually ahead of the schedule we set for ourselves when we first started treating patients," June said. "we pinch ourselves because, you know, until recently we didn’t know if we got lucky or if it would last. our initial patients are still in remission, so we know it’s durable and reproducible. that’s something that makes us excited every day." Source The Lancet Related Itemscancer t cells b cells designer t cells
"The past five years have been a time of explosive, exciting progress in the field of cancer cellular therapy," said June in a statement. "the results we've seen among the leukemia patients we've treated using our 'hunter' cells have accelerated our expectations for the potential of these new therapies. today, many of those brave patients are thriving, and through our work in the cact, we hope to offer that chance to patients with many other types of cancers."

More Content

All (22) | News (20) | Reports (0) | Blogs (2) | Audio/Video (0) | Fact Sheets (0) | Press Releases (0)
sort by: Date | Relevance
Harnessing the Power of Modified T Cells to Tre... [Published PharmTech.com - 9 hours ago]
Philadelphia Ronald McDonald House launches cam... [Published The Daily Pennsylvanian - 19 hours ago]
Nominations open for $100,000 Taubman Prize [Published Newswise - Oct 19 2014]
Lab-Made Blood Cells Hunt Cancer, Leading to Re... [Published The Verge - Oct 15 2014]
Personalized cellular therapy achieves complete... [Published Medical Xpress - Oct 15 2014]
Immunotherapy Study Funded by The Leukemia & Ly... [Published Indianapolis Business Journal - Oct 15 2014]
Taubman Institute awards annual $100,000 resear... [Published Michigan Daily - Oct 12 2014]
In remission or out, Bothell teen enlists his A... [Published HeraldNet - Sep 28 2014]
Adaptimmune gathers $104M to fuel hot immuno-on... [Published FierceBiotech - Sep 25 2014]
Dale Edward Nau [Published Elyria Chronicle Telegram - Sep 24 2014]
UPenn, Wistar Institute to collaborate on $12 m... [Published Orthopedics Today - Sep 19 2014]
Novartis, University Of Pennsylvania To Build C... [Published Bioresearch Online - Sep 16 2014]
CAR T Cells: A Look Under the Hood and Down the... [Published General Medicine eJournal - Sep 16 2014]
Novartis commits $20M to back a new CAR-T resea... [Published FierceBiotech - Sep 11 2014]
The Alliance for Regenerative Medicine Holds Fo... [Published Marketwire - Breaking News Releases - Aug 05 2014]
Lexington grad's ride marks 30 cancer-free years [Published Mansfield News Journal - Jun 26 2014]
Immunotherapies: The New Hope for Cancer Treatment [Published Pharmaceutical Executive - Jun 09 2014]
Leukemia researcher tapped for 2014 Taubman Prize [Published PR Newswire - Jun 04 2014]
Immunotherapy: A Promising New Approach to Trea... [Published UC Television - YouTube - Jun 03 2014]
Dr. Carl June: "Putting the Immune System on St... [Published PRWeb - May 17 2014]
Bryn Mawr couple to be honored as recipients of... [Published Main Line Times - May 06 2014]
What's the Latest in Cancer Therapy? Immunother... [Published PRWeb - Apr 04 2014]
1
In Focus
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
  •  
Content Volume
Document Volume
Network
Network

Blogs

sort by: Date | Relevance
The Alliance for Regenerative Medicine Holds Fo... [Published Marketwire - Breaking News Releases - Aug 05 2014]
Meeting Will Include Plenary Sessions on Latest Developments in Both Gene and Cell Therapy; UPenn's Carl June, M.D. Featured Speaker at Program's Public Forum ...
Immunotherapy: A Promising New Approach to Trea... [Published UC Television - YouTube - Jun 03 2014]
<a style="font-size: 15px; font-weight: bold;font-decoration: none;" href="http://www.youtube.com/watch?v=WcnzetT4ezY&feature=youtube_gdata"&gt;Immunotherapy: A Promising New Approach to Treating Cancer with Carl June MD Visit: http://www.uctv.tv/) ...
1
Contact Us
Sales
Support


Freebase CC-BY Some image thumbnails are sourced from Freebase, licensed under CC-BY

Copyright (C) 2014 Silobreaker Ltd. All rights reserved.
The selection and placement of stories and images on any Silobreaker page are determined automatically by a computer program.
The time or date displayed reflects when an article was added to or updated in Silobreaker.